These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17929795)

  • 1. Potent, orally bioavailable calcitonin gene-related peptide receptor antagonists for the treatment of migraine: discovery of N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1- (2,2,2-trifluoroethyl)azepan-3-yl]-4- (2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin- 1-yl)piperidine-1-carboxamide (MK-0974).
    Paone DV; Shaw AW; Nguyen DN; Burgey CS; Deng JZ; Kane SA; Koblan KS; Salvatore CA; Mosser SD; Johnston VK; Wong BK; Miller-Stein CM; Hershey JC; Graham SL; Vacca JP; Williams TM
    J Med Chem; 2007 Nov; 50(23):5564-7. PubMed ID: 17929795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a potent and orally active calcitonin gene-related peptide receptor antagonist for the treatment of migraine.
    Salvatore CA; Hershey JC; Corcoran HA; Fay JF; Johnston VK; Moore EL; Mosser SD; Burgey CS; Paone DV; Shaw AW; Graham SL; Vacca JP; Williams TM; Koblan KS; Kane SA
    J Pharmacol Exp Ther; 2008 Feb; 324(2):416-21. PubMed ID: 18039958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orally bioavailable imidazoazepanes as calcitonin gene-related peptide (CGRP) receptor antagonists: discovery of MK-2918.
    Paone DV; Nguyen DN; Shaw AW; Burgey CS; Potteiger CM; Deng JZ; Mosser SD; Salvatore CA; Yu S; Roller S; Kane SA; Selnick HG; Vacca JP; Williams TM
    Bioorg Med Chem Lett; 2011 May; 21(9):2683-6. PubMed ID: 21251825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) in human isolated coronary arteries.
    Chan KY; Edvinsson L; Eftekhari S; Kimblad PO; Kane SA; Lynch J; Hargreaves RJ; de Vries R; Garrelds IM; van den Bogaerdt AJ; Danser AH; Maassenvandenbrink A
    J Pharmacol Exp Ther; 2010 Sep; 334(3):746-52. PubMed ID: 20573757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of the (3R,6S)-3-amino-6-(2,3-difluorophenyl)azepan-2-one of telcagepant (MK-0974), a calcitonin gene-related peptide receptor antagonist for the treatment of migraine headache.
    Burgey CS; Paone DV; Shaw AW; Deng JZ; Nguyen DN; Potteiger CM; Graham SL; Vacca JP; Williams TM
    Org Lett; 2008 Aug; 10(15):3235-8. PubMed ID: 18590336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caprolactams as potent CGRP receptor antagonists for the treatment of migraine.
    Shaw AW; Paone DV; Nguyen DN; Stump CA; Burgey CS; Mosser SD; Salvatore CA; Rutledge RZ; Kane SA; Koblan KS; Graham SL; Vacca JP; Williams TM
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4795-8. PubMed ID: 17616394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of (R)-4-(8-fluoro-2-oxo-1,2-dihydroquinazolin-3(4H)-yl)-N-(3-(7-methyl-1H-indazol-5-yl)-1-oxo-1-(4-(piperidin-1-yl)piperidin-1-yl)propan-2-yl)piperidine-1-carboxamide (BMS-694153): a potent antagonist of the human calcitonin gene-related peptide receptor for migraine with rapid and efficient intranasal exposure.
    Degnan AP; Chaturvedula PV; Conway CM; Cook DA; Davis CD; Denton R; Han X; Macci R; Mathias NR; Moench P; Pin SS; Ren SX; Schartman R; Signor LJ; Thalody G; Widmann KA; Xu C; Macor JE; Dubowchik GM
    J Med Chem; 2008 Aug; 51(16):4858-61. PubMed ID: 18665579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MK-8825: a potent and selective CGRP receptor antagonist with good oral activity in rats.
    Bell IM; Stump CA; Gallicchio SN; Staas DD; Zartman CB; Moore EL; Sain N; Urban M; Bruno JG; Calamari A; Kemmerer AL; Mosser SD; Fandozzi C; White RB; Zrada MM; Selnick HG; Graham SL; Vacca JP; Kane SA; Salvatore CA
    Bioorg Med Chem Lett; 2012 Jun; 22(12):3941-5. PubMed ID: 22607672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzodiazepine calcitonin gene-related peptide (CGRP) receptor antagonists: optimization of the 4-substituted piperidine.
    Burgey CS; Stump CA; Nguyen DN; Deng JZ; Quigley AG; Norton BR; Bell IM; Mosser SD; Salvatore CA; Rutledge RZ; Kane SA; Koblan KS; Vacca JP; Graham SL; Williams TM
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5052-6. PubMed ID: 16889959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo quantification of calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain using the positron emission tomography tracer [11C]MK-4232.
    Hostetler ED; Joshi AD; Sanabria-Bohórquez S; Fan H; Zeng Z; Purcell M; Gantert L; Riffel K; Williams M; O'Malley S; Miller P; Selnick HG; Gallicchio SN; Bell IM; Salvatore CA; Kane SA; Li CC; Hargreaves RJ; de Groot T; Bormans G; Van Hecken A; Derdelinckx I; de Hoon J; Reynders T; Declercq R; De Lepeleire I; Kennedy WP; Blanchard R; Marcantonio EE; Sur C; Cook JJ; Van Laere K; Evelhoch JL
    J Pharmacol Exp Ther; 2013 Nov; 347(2):478-86. PubMed ID: 23975906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of human calcitonin gene-related peptide (CGRP) receptor antagonists. 1. Potent and selective small molecule CGRP antagonists. 1-[N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-l-lysyl]-4-(4-pyridinyl)piperazine: the first CGRP antagonist for clinical trials in acute migraine.
    Rudolf K; Eberlein W; Engel W; Pieper H; Entzeroth M; Hallermayer G; Doods H
    J Med Chem; 2005 Sep; 48(19):5921-31. PubMed ID: 16161996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitonin gene-related peptide (CGRP) receptor antagonists: investigations of a pyridinone template.
    Nguyen DN; Paone DV; Shaw AW; Burgey CS; Mosser SD; Johnston V; Salvatore CA; Leonard YM; Miller-Stein CM; Kane SA; Koblan KS; Vacca JP; Graham SL; Williams TM
    Bioorg Med Chem Lett; 2008 Jan; 18(2):755-8. PubMed ID: 18039571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining the binding properties of MK-0974: a CGRP receptor antagonist for the acute treatment of migraine.
    Moore EL; Burgey CS; Paone DV; Shaw AW; Tang YS; Kane SA; Salvatore CA
    Eur J Pharmacol; 2009 Jan; 602(2-3):250-4. PubMed ID: 19084002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversed-phase chiral liquid chromatography on polysaccharide-based stationary phase coupled with tandem mass spectrometry for simultaneous determination of four stereoisomers of MK-0974 in human plasma.
    Xu Y; Musson DG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Oct; 873(2):195-202. PubMed ID: 18799366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitonin gene-related peptide (CGRP) receptor antagonists: pyridine as a replacement for a core amide group.
    Luo G; Chen L; Civiello R; Pin SS; Xu C; Kostich W; Kelley M; Conway CM; Macor JE; Dubowchik GM
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2917-21. PubMed ID: 22429470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telcagepant, a calcitonin gene-related peptide antagonist for the treatment of migraine.
    Tepper SJ; Cleves C
    Curr Opin Investig Drugs; 2009 Jul; 10(7):711-20. PubMed ID: 19579177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-peptide calcitonin gene-related peptide receptor antagonists from a benzodiazepinone lead.
    Williams TM; Stump CA; Nguyen DN; Quigley AG; Bell IM; Gallicchio SN; Zartman CB; Wan BL; Penna KD; Kunapuli P; Kane SA; Koblan KS; Mosser SD; Rutledge RZ; Salvatore C; Fay JF; Vacca JP; Graham SL
    Bioorg Med Chem Lett; 2006 May; 16(10):2595-8. PubMed ID: 16527483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of (5S,6S,9R)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl 4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxylate (BMS-927711): an oral calcitonin gene-related peptide (CGRP) antagonist in clinical trials for treating migraine.
    Luo G; Chen L; Conway CM; Denton R; Keavy D; Signor L; Kostich W; Lentz KA; Santone KS; Schartman R; Browning M; Tong G; Houston JG; Dubowchik GM; Macor JE
    J Med Chem; 2012 Dec; 55(23):10644-51. PubMed ID: 23153230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of (R)-N-(3-(7-methyl-1H-indazol-5-yl)-1-(4-(1-methylpiperidin-4-yl)-1-oxopropan-2-yl)-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-carboxamide (BMS-742413): a potent human CGRP antagonist with superior safety profile for the treatment of migraine through intranasal delivery.
    Chaturvedula PV; Mercer SE; Pin SS; Thalody G; Xu C; Conway CM; Keavy D; Signor L; Cantor GH; Mathias N; Moench P; Denton R; Macci R; Schartman R; Whiterock V; Davis C; Macor JE; Dubowchik GM
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3157-61. PubMed ID: 23632269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological properties of MK-3207, a potent and orally active calcitonin gene-related peptide receptor antagonist.
    Salvatore CA; Moore EL; Calamari A; Cook JJ; Michener MS; O'Malley S; Miller PJ; Sur C; Williams DL; Zeng Z; Danziger A; Lynch JJ; Regan CP; Fay JF; Tang YS; Li CC; Pudvah NT; White RB; Bell IM; Gallicchio SN; Graham SL; Selnick HG; Vacca JP; Kane SA
    J Pharmacol Exp Ther; 2010 Apr; 333(1):152-60. PubMed ID: 20065019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.